David L. Morris, MD
Co-Founder, Inventor & CTO
Dr. Morris is a specialist in surgical oncology with a focus on peritoneal cancers, liver tumors, treatment of liver and lung metastasis of colorectal cancer and hydatid disease.
Dr. Morris is a Professor of Surgery at St. George Hospital & University of New South Wales.
Dr. Morris is well published with >700 journal articles, 20 book chapters and books, >20 patents, and numerous conference abstracts and presentations.
Mr. Turner is a seasoned medical device marketing professional and executive with over 30 years of experience.
Previously, Mr. Turner served as General Manager and held senior marketing roles with Medtronic (16 years), Johnson & Johnson Medical, Sorin Group and Smith&Nephew Endoscopy.
Mr. Herszberg is a philanthropist and a leading executive in the consumer electronics, computers, software and cellular communications industries with over 40 years of experience.
Previously, Mr. Herszberg served as Director at Pacmag Metals Ltd. (formerly Pacific Magnesium Corporation Ltd.) and Infomedia Ltd.
Mr. Herszberg is the Founder of the Denman Audio electronics chain and Board Member at Axiom Energy Ltd.
Co-Founder & CEO
INCIRCLE® sterile, single-use instruments are indicated for thermal coagulation of soft tissues. They have been used routinely in percutaneous, laparoscopic and open surgical approaches, e.g. in the following B-RFA procedures for:
Hepatocellular carcinoma (HCC), colorectal cancer hepatic metastases (CRCHM), liver metastases, gallbladder carcinoma, or hepatic adenoma
Large-volume, symptomatic hepatic cavernous haemangioma of >10 cm
Parenchymal pre-coagulation prior to transection
Ex Vivo Perfusion Model
INCIRCLE® utilizes the company’s innovative and proprietary bipolar ablation technology.
INLINE® utilizes a variation of the company’s innovative and proprietary bipolar ablation technology. Its main advantages are:
+ Effective Pre-Coagulation
+ Minimizes Blood Loss
INLINE® sterile, single-use instruments are indicated to coagulate tissue during laparoscopic and intraoperative surgical procedures. They have been used routinely for:
Parenchymal pre-coagulation prior to open, laparoscopic, or laparoscopic hand-assisted liver resection for primary and metastatic liver tumors or focal nodular hyperplasia
Cirrhotic, post chemotherapy fibrosis, and fatty livers
RFA MEDICAL, Inc.
San Francisco, CA
Tel: +1 (877) 317 3175
RFA MEDICAL, Inc. is a technology leader in bipolar tissue ablation and offering an innovative alternative to traditional monopolar RF or microwave ablation. The company’s proprietary core technology has dual bipolar probes with deployable coils for unique no-touch, outside-to-inside ablation of soft tissues. RFA Medical competes within the rapidly growing market for tumor ablation technologies, which has an estimated market size of $900 million worldwide.
For any general inquiries, please fill in the following contact form:
RFA MEDICAL's proprietary technology uniquely leverages bipolar radiofrequency (RF) energy for the thermal coagulation of soft tissues. It has been utilized routinely around the globe for liver ablations including primary and secondary liver malignancies of sizes small to large.
Our forward-thinking innovations shift from reliance on thermal conduction for tissue heating and cell death to targeted tissue heating with minimal heat sink effects. Our technologies combines fast, direct, and homogeneous tissue heating with an innovative “outside-to-inside” and “line-of-sight” approach to energy delivery.
> 3 cm
LARGE ABLATION ZONE
> 5 mm
EXPERIENCE WHAT'S NEXT
We are a passionate team devoted to pushing the boundaries of thermal ablation in oncological procedures.
We believe that thermal ablation should allow you to ablate large and solid or metastatic tumors in a controllable and predictable manner – independent of the ablative progress, the anatomy or vascular perfusion. We thrive in providing innovative solutions for improving oncological outcomes – reliably and repeatably.
Advancing Ablation Boundaries
Effect of Change in Portal Vein Flow Rates on Hepatic Ablations Created with a Bipolar Radiofrequency Ablation Device
Dodd GD 3rd, Lanctot AC, Lind KE. Radiology. 2017 May;283(2):399-407.
"Edgeboost": A Novel Technique to Extend the Ablation Zone Lateral to a Two-Probe Bipolar Radiofrequency Device
Huo YR, Pillai K, Akhter J, Morris DL. Cardiovasc Intervent Radiol. 2016 Jan;39(1):97-105.
Effect of nonparallel placement of in-circle bipolar radiofrequency ablation probes on volume of tissue ablated with heat sink
Pillai K, Al-Alem I, Akhter J, Chua TC, Shehata M, Morris DL. Surg Innov. 2015 Jun;22(3):223-34.
Bipolar radiofrequency ablation for symptomatic giant (>10 cm) hepatic cavernous haemangiomas: initial clinical experience
van Tilborg AA, Nielsen K, Scheffer HJ, van den Tol P, van Waesberghe JH, Sietses C, Meijerink MR. Clin Radiol. 2013 Jan;68(1):e9-e14.
Heat sink phenomenon of bipolar and monopolar radiofrequency ablation observed using polypropylene tubes for vessel simulation
Al-Alem I, Pillai K, Akhter J, Chua TC, Morris DL. Surg Innov. 2014 Jun;21(3):269-76.
Bipolar radiofrequency ablation of liver tumors: technical experience and interval follow-up in 22 patients with 33 ablations
Baldwin K, Katz SC, Rubin A, Somasundar P. J Surg Oncol. 2012 Dec;106(7):905-10.
Liver resection using bipolar InLine multichannel radiofrequency device: impact on intra- and peri-operative outcomes
Daylami R, Kargozaran H, Khatri VP. Eur J Surg Oncol. 2012 Jun;38(6):531-6.
Comparative study of radiofrequency ablation (RFA) of a novel bipolar probe with a unipolar probe (in the presence and absence of vessel simulation), using egg white and ex-vivo liver model
Akhter, J., Pillai, K., Al-Alem, I., & Morris, D. L. ANZ Journal of Surgery ,2012 pp. 93.
Laparoscopic treatment of liver tumours using a two-needle probe bipolar radiofrequency ablation device
Alemi F, Kwon E, Chiu J, Aoki H, Stewart L, Corvera CU. HPB (Oxford). 2011 Sep;13(9):656-64.
Radiofrequency ablation of large size liver tumours using novel plan-parallel expandable bipolar electrodes: Initial clinical experience
Meijerink MR, van den Tol P, van Tilborg AA, van Waesberghe JH, Meijer S, van Kuijk C. Eur J Radiol. 2011 Jan;77(1):167-71.
Radiofrequency-assisted hepatectomy using bipolar Inline multichannel radiofrequency device (ILMRD): report of initial clinical experience
Kargozaran H, Wildendorf S, Khatri VP. Hepatogastroenterology. 2009 Sep-Oct;56(94-95):1496-500.
Novel laparoscopic bipolar radiofrequency energy technology for expedited hepatic tumour ablation
Yi B, Somasundar P, Espat NJ. HPB (Oxford). 2009 Mar; 11(2): 135–139.doi
Radiofrequency ablation of liver tumors using a novel bipolar device
Eisele RM, Neuhaus P, Schumacher G. J Laparoendosc Adv Surg Tech A. 2008 Dec;18(6):857-63.
Treatment of Liver Tumours: Using a Novel Bipolar Radiofrequency Device
Aoki H, Way L, Corvera C. SAGES Annual Meeting 2008, P393.
A multicentre controlled study of the InLine radiofrequency ablation device for liver transection
Yao P, Chu F, Daniel S, Gunasegaram A, Yan T, Lindemann W, Pistorius G, Schilling M, Machi J, Zuckerman R, Morris DL. HPB (Oxford). 2007;9(4):267-71.
InLine radiofrequency ablation-assisted laparoscopic liver resection: first experiment with stapling device
Yao P, Gunasegaram A, Ladd LA, Chu F, Morris DL. ANZ J Surg. 2007 Jun;77(6):480-4.
A prospective study of in-line radiofrequency ablation in hepatic parenchymal transection--its efficacy and complications
Yan TD, Kusyk T, Daniel S, Chu F, Gunasegaram A, Chang D, Morris DL. HPB (Oxford). 2006;8(4):287-91.
Controlled study of Inline radiofrequency coagulation-assisted partial nephrectomy in sheep
Haghighi KS, Steinke K, Hazratwala K, Kam PC, Daniel S, Morris DL. J Surg Res. 2006 Jun 15;133(2):215-8.
In-line radiofrequency ablation to minimize blood loss in hepatic parenchymal transection
Haghighi KS, Wang F, King J, Daniel S, Morris DL. Am J Surg. 2005 Jul;190(1):43-7.
Controlled study of inline radiofrequency ablation (ILRFA) assisted transection of ovine liver
Haghighi KS, Steinke K, Hazratwala K, Kam PC, Daniel S, Morris DL. J Surg Res. 2005 Jan;123(1):139-43.
Novel in-line multielectrode radiofrequency ablation considerably reduces blood loss during liver resection in an animal model
Gananadha S, Morris DL. ANZ J Surg. 2004 Jun;74(6):482-5.